Quick Takeaways
- Metin Kurtoglu has 1 issuer position tracked on this page.
- Estimated disclosed ownership value: $1,110,427.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Metin Kurtoglu
- Location
- Gaithersburg, MD
- Summary
- The estimated net worth of Metin Kurtoglu is at least $1,110,427 dollars as of 07 Jan 2025. Metin Kurtoglu is the Chief Technology Officer of Cartesian Therapeutics, Inc. and owns shares of Cartesian Therapeutics, Inc. (RNAC) stock worth about $1.11M.
- Signature
- /s/ Matthew Bartholomae, Attorney-in-Fact for Metin Kurtoglu
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Metin Kurtoglu and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
What Changed
- Largest disclosed position: Cartesian Therapeutics, Inc. ($1,110,427).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Official SEC Source
Filed on Form 4
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original FilingOwnership of Metin Kurtoglu
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| RNAC | Cartesian Therapeutics, Inc. | Chief Technology Officer | $1,110,427 | 03 Jan 2025 |
Insider Transactions Reported by Metin Kurtoglu:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.